yasser bustanji
University of Sharjah
Sharjah, United Arab Emirates
Review Editor
Pharmacology of Anti-Cancer Drugs
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Editorial Board
Type at least 3 characters
1,064 editors
Shape the future of research in your field
Join the board
Editors
Review Editors
sanguine byun
Yonsei University
Seoul, Republic of Korea
Review Editor
Pharmacology of Anti-Cancer Drugs
dr. michael ch chau
Tung Wah College
Kowloon, Hong Kong, SAR China
Review Editor
Pharmacology of Anti-Cancer Drugs
cristina caffarra malvezzi
University of Turin
Turin, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
laia caja
Uppsala University
Uppsala, Sweden
Review Editor
Pharmacology of Anti-Cancer Drugs
anna rita cantelmo
Université Lille Nord de France
Lille, France
Review Editor
Pharmacology of Anti-Cancer Drugs
xuni cao
East China University of Science and Technology
Shanghai, China
Review Editor
Pharmacology of Anti-Cancer Drugs
zhengyu cao
China Pharmaceutical University
Nanjing, China
Review Editor
Pharmacology of Anti-Cancer Drugs
carsten carlberg
Institute of Animal Reproduction and Food Research, Polish Academy of Sciences
Olsztyn, Poland
Review Editor
Pharmacology of Anti-Cancer Drugs
daniela carlisi
University of Palermo
Palermo, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
celeste caruso bavisotto
Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo
Palermo, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
elena catanzaro
Ghent University
Ghent, Belgium
Review Editor
Pharmacology of Anti-Cancer Drugs
chiara cervetto
University of Genoa
Genoa, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
ben chung lap chan
The Chinese University of Hong Kong
Shatin, China
Review Editor
Pharmacology of Anti-Cancer Drugs
hoi huen chan
The Education University of Hong Kong
Tai Po, Hong Kong, SAR China
Review Editor
Pharmacology of Anti-Cancer Drugs
ki chan
The University of Hong Kong
Pokfulam, Hong Kong, SAR China
Review Editor
Pharmacology of Anti-Cancer Drugs